✦ LIBER ✦

Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?

✍ Scribed by Attivi, D.; Gibaud, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

✍ Butterfield, J. M.; Lodise, T. P.; Beegle, S.; Rosen, J.; Farkas, J.; Pai, M. P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 171 KB

Pharmacokinetics of piperacillin and taz

✍ T. S. van der Werf; P. O. M. Mulder; J. G. Zijlstra; D. R. A. Uges; C. A. Stegem 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 79 KB

Population pharmacokinetics of piperacil

✍ Asin-Prieto, E.; Rodriguez-Gascon, A.; Troconiz, I. F.; Soraluce, A.; Maynar, J. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 555 KB

Pharmacoeconomics of Piperacillin/Tazoba

✍ Stanford S. Jhee; Mark A. Gill; Albert E. Yellin; Thomas V. Berne; Peter N.R. He 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 451 KB

A randomized clinical trial of ceftriaxo

✍ Fausto Rossini; Elisabetta Terruzzi; Luisa Verga; Alessandra Larocca; Sara Marin 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 83 KB

Treatment of herpes virus infections in

✍ Stephen A. Spector; Marie Hintz; Cheryl Wyborny; James D. Connor; Ronald E. Keen 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 549 KB